{"Title": "Cannabis derived medicinal products in child neurology", "Year": 2019, "Source": "Dev. Med. Child Neurol.", "Volume": "61", "Issue": 6, "Art.No": null, "PageStart": 622, "PageEnd": null, "CitedBy": 0, "DOI": "10.1111/dmcn.14232", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064542509&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Cannabinoids", "Cannabis", "Child", "Humans", "Muscle Spasticity", "Neurology"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85064542509", "SubjectAreas": [["Pediatrics, Perinatology and Child Health", "MEDI", "2735"], ["Developmental Neuroscience", "NEUR", "2806"], ["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"7004263408": {"Name": "O'callaghan F.", "AuthorID": "7004263408", "AffiliationID": "60012662", "AffiliationName": "Paediatric Neuroscience, UCL Great Ormond Street Institute of Child Health"}}}